Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 16/20 | 0.70 |
| ▸ | RAB9A | P51151 | 13/20 | 0.70 |
| ▸ | NPC1 | O15118 | 13/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.70 |
| ▸ | MEN1 | O00255 | 11/20 | 0.70 |
| ▸ | GAA | P10253 | 10/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.66 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.66 |
| ▸ | RELA | Q04206 | 4/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 5/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.65 |
| ▸ | TP53 | P04637 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1231354 | 1.00 | MAPT (0.70) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL10038665 | 0.90 | MAPT (0.65) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL1165591 | 0.88 | MAPT (0.68) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL1165592 | 0.88 | MAPT (0.68) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL28684828 | 0.88 | MAPT (0.61) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL21010612 | 0.85 | MAPT (0.68) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL13779288 | 0.82 | MAPT (0.75) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL22103769 | 0.81 | MAPT (0.64) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL27701871 | 0.81 | MAPT (0.62) | MAPTRAB9ANPC1KMT2AMEN1 | |
| SCHEMBL17123531 | 0.81 | MAPT (0.67) | MAPTRAB9ANPC1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8617897-B2 | Method of detecting oxides of nitrogen | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-12-31 | — | — | US | claimed |
| EP-2462441-A1 | METHOD OF DETECTING OXIDES OF NITROGEN | 3M Innovative Properties Company (US) | 2012-06-13 | — | — | EP | claimed |
| US-20120129266-A1 | METHOD OF DETECTING OXIDES OF NITROGEN | 3M INNOVATIVE PROPERTIES COMPANY | 2012-05-24 | — | — | US | claimed |
| WO-2011017317-A1 | METHOD OF DETECTING OXIDES OF NITROGEN | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-02-10 | — | — | WO | claimed |
| EP-3789472-B1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION FOR OPTICAL ELEMENT, POLYMER, OPTICALLY ANISOTROPIC BODY, AND OPTICAL ELEMENT FOR DISPLAY DEVICE | LG CHEMICAL LTD (KR) | 2025-04-16 | — | — | EP | disclosed |
| US-11914248-B2 | Photo-alignment copolymer, photo-alignment film, and optical laminate | FUJIFILM CORPORATION (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20230296820-A1 | POLARIZING PLATE AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-11746295-B2 | Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate, and image display device | FUJIFILM CORPORATION (JP) | 2023-09-05 | — | — | US | disclosed |
| US-11732191-B2 | Compound, polymerizable composition, cured product, optical film, polarizing plate, and image display device | FUJIFILM CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| US-11726367-B2 | Phase difference film, method for manufacturing phase difference film, polarizing plate, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2023-08-15 | — | — | US | disclosed |
| US-20230228928-A1 | OPTICAL LAMINATE, POLARIZING PLATE, AND IMAGE DEVICE DISPLAY | FUJIFILM CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20230183574-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL CURED LAYER, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-20160015835-A1 | LUCIFERIN DERIVATIVES FROM BICYCLIC REACTANTS AND AMINOTHIOL DERIVATIVES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-01-21 | — | — | US | disclosed |
| US-9173966-B2 | Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150072966-A1 | METHOD OF PROMOTING WOUND HEALING | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-03-12 | — | — | US | disclosed |
| US-8617897-B2 | Method of detecting oxides of nitrogen | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-12-31 | — | — | US | disclosed |
| US-20130287699-A1 | Luciferin Derivatives from Bicyclic Reactants and Aminothiol Derivatives and Methods of Use Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2013-10-31 | — | — | US | disclosed |
| EP-2462441-A1 | METHOD OF DETECTING OXIDES OF NITROGEN | 3M Innovative Properties Company (US) | 2012-06-13 | — | — | EP | disclosed |
| US-20120129266-A1 | METHOD OF DETECTING OXIDES OF NITROGEN | 3M INNOVATIVE PROPERTIES COMPANY | 2012-05-24 | — | — | US | disclosed |
| WO-2011017317-A1 | METHOD OF DETECTING OXIDES OF NITROGEN | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130287699-A1 | Luciferin Derivatives from Bicyclic Reactants and Aminothiol Derivatives and Methods of Use Thereof | GFPT1, QPCT, GLB1 | MAPT 3324/4885RAB9A 4461/4885NPC1 3707/4885 |
| US-20150072966-A1 | METHOD OF PROMOTING WOUND HEALING | NOS3, NOS1, NOS2 | MAPT 4876/4885RAB9A 2130/4885NPC1 4456/4885 |
| US-20160015835-A1 | LUCIFERIN DERIVATIVES FROM BICYCLIC REACTANTS AND AMINOTHIOL DERIVATIVES AND METHODS OF USE THEREOF | GFPT1, QPCT, GLB1 | MAPT 3324/4885RAB9A 4461/4885NPC1 3707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.